Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

Triple-negative breast cancer (TNBC) lacks targeted therapies and has a worse prognosis than other breast cancer subtypes, underscoring an urgent need for new therapeutic targets and strategies. IRE1 is an endoplasmic reticulum (ER) stress sensor, whose activation is predominantly linked to the reso...

Descripción completa

Detalles Bibliográficos
Autores principales: Logue, Susan E., McGrath, Eoghan P., Cleary, Patricia, Greene, Stephanie, Mnich, Katarzyna, Almanza, Aitor, Chevet, Eric, Dwyer, Róisín M., Oommen, Anup, Legembre, Patrick, Godey, Florence, Madden, Emma C., Leuzzi, Brian, Obacz, Joanna, Zeng, Qingping, Patterson, John B., Jäger, Richard, Gorman, Adrienne M., Samali, Afshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093931/
https://www.ncbi.nlm.nih.gov/pubmed/30111846
http://dx.doi.org/10.1038/s41467-018-05763-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093931/
https://www.ncbi.nlm.nih.gov/pubmed/30111846
http://dx.doi.org/10.1038/s41467-018-05763-8

Ejemplares similares